KRM Ayurveda Ltd

KRM Ayurveda Limited delivered a robust financial performance in FY26, with revenue from operations growing 32.84% year-on-year to ₹101.69 crores. Profitability scaled significantly, as EBITDA reached ₹31.12 crores, marking a 62.59% YoY increase, with margins expanding to 30.60% from 25% in the prior year. Net profit (PAT) also saw substantial growth of 79.42% YoY, reaching ₹20.12 crores, and PAT margins improved to 19.79%. This performance reflects strong operating leverage and improved revenue quality.

As of FY26, the company operates six hospitals and multiple clinics across India, with over 220 beds and an average occupancy rate of 69%. The dual revenue model is balanced, with 53.8% from services and 46.2% from products. The digital ecosystem has grown to include approximately eight lakh subscribers across all platforms, supporting global reach and efficient scaling through digital and teleconsultation platforms. The company's IPO on NSE Merge was oversubscribed 74 times, demonstrating strong investor confidence.

KRM Ayurveda plans significant expansion, targeting 1,500 to 2,000 beds and 100 super-specialty clinics across India over the next three years. For the current financial year (FY27), the company aims to increase bed capacity from approximately 235 to 500 beds and add 30 new clinics. A luxury wellness hospital with 25 beds in Delhi is expected to be operational within three months, catering to a high-ticket-size patient segment (₹15,000-20,000 per day).

Following its successful IPO, KRM Ayurveda has repaid its entire debt, making the company completely debt-free. This strong balance sheet supports future growth initiatives. The company emphasizes capital efficiency, with CAPEX for expansion largely funded through internal accruals, and a strategic approach to new facility openings that aims for breakeven from day one by leveraging existing patient bases and digital presence. Hospital setup costs are approximately ₹2.5-3 lakh per bed, while day-care centers cost ₹15-20 lakh.

The company operates on a system-driven model, rather than being doctor-dependent, with over 40 experienced doctors adhering to standardized SOPs and protocols. A strong emphasis is placed on R&D, led by a Head with 18 years of manufacturing experience, and supported by 15 MDs, including 5 specializing in product design and formulation. This focus ensures product efficacy and consistent patient outcomes, contributing to a high rate of patient referrals and reducing marketing expenses.

KRM Ayurveda is developing a 500-seater telemedicine center, expected to be operational within 1 to 1.5 years, which is projected to at least double revenue from products and services. This center will act as a backend system and acquisition funnel. The company is also expanding its product portfolio, with 20 products already finalized and 15 food supplements slated for launch within the next 15-20 days, further diversifying revenue streams and supporting the wellness focus.